Juiz de Fora, Brazil

Centro Mineiro de Pesquisa

Kidney Diseases

Nephritis

Rheumatoid Arthritis

Lupus Nephritis

Dermatomyositis

Myositis

Arthritis

IGA Glomerulonephritis

Systemic Lupus Erythematosus

Daxdilimab

Povetacicept

SAR441566

HZN-7734

Amgen

Bristol-Myers Squibb (BMS)

Sanofi

Alpine Immune Sciences Inc, A Subsidiary of Vertex

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserving renal function.

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

Centro Mineiro de Pesquisa | Juiz de Fora, Brazil

Site insights

Work at this site?

Active trials

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

Trial sponsors